223 related articles for article (PubMed ID: 29916361)
21. [Recommendations about Multiple Sclerosis Management during Pregnancy, Partum and Post-Partum: Consensus Position of the Portuguese Multiple Sclerosis Study Group].
Batista S; Martins da Silva A; Sá MJ; Sousa L; De Sá J; Pedrosa R; Cerqueira J; Pinheiro J; Abreu P; Simões RM; Vale J
Acta Med Port; 2020 Sep; 33(9):611-621. PubMed ID: 32893778
[TBL] [Abstract][Full Text] [Related]
22. New concepts about the role of magnetic resonance imaging in the diagnosis and follow-up of multiple sclerosis.
Auger C; Rovira À
Radiologia (Engl Ed); 2020; 62(5):349-359. PubMed ID: 32861433
[TBL] [Abstract][Full Text] [Related]
23. [Recommendations About Multiple Sclerosis Management During Pregnancy, Partum and Post-Partum: Consensus Position of The Portuguese Multiple Sclerosis Study Group and The Portuguese Society of Obstetrics and Maternal-Fetal Medicine].
Batista S; Silva AM; Sá MJ; Sousa L; De Sá J; Pedrosa R; Cerqueira J; Pinheiro J; Abreu P; Simões RM; Dias E; Veríssimo C; Vale J
Acta Med Port; 2018 Dec; 31(12):785-795. PubMed ID: 30684378
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for useful serum testing with suspected multiple sclerosis.
Ouallet JC; Bodiguel E; Bensa C; Blanc F; Brassat D; Laplaud D; Zephir H; de Seze J; Magy L;
Rev Neurol (Paris); 2013 Jan; 169(1):37-46. PubMed ID: 22325711
[TBL] [Abstract][Full Text] [Related]
25. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
Colombini D; Occhipinti E
Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
[TBL] [Abstract][Full Text] [Related]
26. Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update.
Duarte AC; Santos-Faria D; Gonçalves MJ; Sepriano A; Mourão AF; Duarte C; Neves JS; Águeda AF; Ribeiro PA; Daniel A; Neto A; Cordeiro A; Rodrigues A; Barcelos A; Silva C; Ponte C; Vieira-Sousa E; Teixeira F; Oliveira-Ramos F; Araújo F; Barcelos F; Canhão H; Santos H; Ramos J; Polido-Pereira J; Tavares-Costa J; Melo Gomes JA; Cunha-Miranda L; Costa L; Cerqueira M; Cruz M; Santos MJ; Bernardes M; Oliveira P; Abreu P; Figueira R; Barros R; Falcão S; Pinto P; Pimenta S; Capela S; Teixeira V; Fonseca JE
Acta Reumatol Port; 2017; 42(2):127-140. PubMed ID: 28535545
[TBL] [Abstract][Full Text] [Related]
27. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
International Liaison Committee on Resuscitation
Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
[TBL] [Abstract][Full Text] [Related]
28. MR imaging in multiple sclerosis: review and recommendations for current practice.
Lövblad KO; Anzalone N; Dörfler A; Essig M; Hurwitz B; Kappos L; Lee SK; Filippi M
AJNR Am J Neuroradiol; 2010 Jun; 31(6):983-9. PubMed ID: 20019103
[TBL] [Abstract][Full Text] [Related]
29. MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update.
Wattjes MP; Steenwijk MD; Stangel M
Clin Neuroradiol; 2015 Oct; 25 Suppl 2():157-65. PubMed ID: 26198879
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
Filippi M; Horsfield MA; Adèr HJ; Barkhof F; Bruzzi P; Evans A; Frank JA; Grossman RI; McFarland HF; Molyneux P; Paty DW; Simon J; Tofts PS; Wolinsky JS; Miller DH
Ann Neurol; 1998 Apr; 43(4):499-506. PubMed ID: 9546332
[TBL] [Abstract][Full Text] [Related]
31. The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group.
Mushlin AI; Detsky AS; Phelps CE; O'Connor PW; Kido DK; Kucharczyk W; Giang DW; Mooney C; Tansey CM; Hall WJ
JAMA; 1993 Jun 23-30; 269(24):3146-51. PubMed ID: 8505818
[TBL] [Abstract][Full Text] [Related]
32. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.
Sati P; Oh J; Constable RT; Evangelou N; Guttmann CR; Henry RG; Klawiter EC; Mainero C; Massacesi L; McFarland H; Nelson F; Ontaneda D; Rauscher A; Rooney WD; Samaraweera AP; Shinohara RT; Sobel RA; Solomon AJ; Treaba CA; Wuerfel J; Zivadinov R; Sicotte NL; Pelletier D; Reich DS;
Nat Rev Neurol; 2016 Dec; 12(12):714-722. PubMed ID: 27834394
[TBL] [Abstract][Full Text] [Related]
33. Consensus document on chronic coronary syndrome assessment and risk stratification in Portugal: A position paper statement from the [Portuguese Society of Cardiology's] Working Groups on Nuclear Cardiology, Magnetic Resonance and Cardiac Computed Tomography, Echocardiography, and Exercise Physiology and Cardiac Rehabilitation.
Bettencourt N; Mendes L; Fontes JP; Matos P; Ferreira C; Botelho A; Carvalho S; Durazzo A; Faustino A; Ladeiras Lopes R; Vasconcelos M; Vieira C; Correia M; Ferreira AM; Ferreira N; Pires-Morais G; G Almeida A; Ferreira MJV; Teixeira M;
Rev Port Cardiol; 2022 Mar; 41(3):241-251. PubMed ID: 33342714
[TBL] [Abstract][Full Text] [Related]
34. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
[TBL] [Abstract][Full Text] [Related]
35. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
Freedman MS; Devonshire V; Duquette P; Giacomini PS; Giuliani F; Levin MC; Montalban X; Morrow SA; Oh J; Rotstein D; Yeh EA;
Can J Neurol Sci; 2020 Jul; 47(4):437-455. PubMed ID: 32654681
[TBL] [Abstract][Full Text] [Related]
36. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Rovira À; Wattjes MP; Tintoré M; Tur C; Yousry TA; Sormani MP; De Stefano N; Filippi M; Auger C; Rocca MA; Barkhof F; Fazekas F; Kappos L; Polman C; Miller D; Montalban X;
Nat Rev Neurol; 2015 Aug; 11(8):471-82. PubMed ID: 26149978
[TBL] [Abstract][Full Text] [Related]
37. MRI in multiple sclerosis: clinical and research update.
Inglese M; Petracca M
Curr Opin Neurol; 2018 Jun; 31(3):249-255. PubMed ID: 29561520
[TBL] [Abstract][Full Text] [Related]
38. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.
Gold R; Oreja-Guevara C
Expert Rev Neurother; 2013 Dec; 13(12 Suppl):55-9. PubMed ID: 24289845
[TBL] [Abstract][Full Text] [Related]
39. Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.
Dong J; Zhao Y; Petkau AJ; Li DK; Riddehough A; Traboulsee A
Mult Scler; 2015 Jan; 21(1):101-4. PubMed ID: 24852923
[TBL] [Abstract][Full Text] [Related]
40. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
